2009 update of the ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction and guidelines on percutaneous coronary intervention: What should we change in clinical practice?

Polskie Archiwum Medycyny Wewnetrznej

Volumn 120, Issue 1-2, 2010, Pages 6-8

  King III, Spencer B ^a  

^a Saint Joseph's Heart and Vascular Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ANTICOAGULANT AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; PRASUGREL; THIENOPYRIDINE DERIVATIVE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG ELUTING STENT; EDITORIAL; EVIDENCE BASED MEDICINE; HEART INFARCTION; HUMAN; MEDICAL DECISION MAKING; MEDICAL SOCIETY; MEDICAL SPECIALIST; PATIENT CARE; PATIENT TRANSPORT; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; ST SEGMENT ELEVATION; STENT; TREATMENT DURATION;

EID: 77649254107     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (14)

1. Kushner FG, Hand M, Smith SC Jr, King SB III, et al. 2009 focused update of the ACC/AHA guidelines for the management of patients with ST-Elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and the ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009; 54: 2205-2241.
2. King SB, Smith SC, Hirshfeld JW Jr, et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol. 2008; 51: 172-209.
3. Mehilli J, Kastrati A, Schutz s, et at. Abciximab in patients with acute ST-segement-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial. Circulation. 2009; 119: 1933-1940.
4. Van't Hof AW, Ten Berg J, Heestermans T, et al. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomized controlled trial. Lancet. 2008; 372: 537-546.
5. Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008; 358: 2218-2230.
6. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007; 357: 2001-2015.
7. Di Mario C, Dudek D, Piscione F, et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab Reteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomized, multi-centre trial. Lancet. 2008; 371: 559-568.
8. Cantor WJ, Fitchett D, Borgundvaag B, et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med. 2009; 360: 2705-2718.
9. Svilaas T, Vlaar PJ, van der Horst I, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008; 358: 557-567.
10. Stone GW, Lansky AJ, Pocock SJ, et al. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med. 2009; 360: 1946-1959.
11. Reed M, Meier P, Tamhane UU, et al. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials. J Am Coll Cardiol Intv. 2009; 2: 645-654.
12. Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009; 360: 213-224.
13. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009; 360: 961-972.
14. Montalescot G. Angioplasty to blunt the rise of troponin in acute coronary syndromes randomized for an immediate or delayed intervention. http://www.theheart.org/article/954535.do. Accessed August 3, 2009.